Skip to main content

New report calls for personalised testing for safety and effectiveness of common medicines throughout the NHS

Testing patients for genetic variations that affect how their body will respond to common medicines must be integrated fully, fairly and swiftly into the NHS, according to a report published today. The report is by the British Pharmacological Society, whose President-elect is Queen Mary University of London’s Vice Principal for Health Professor Sir Mark Caulfield, and the Royal College of Physicians.  Dr Emma Magavern, a clinician at Queen Mary, is also one of the report’s co-authors.

Published on:
Back to top